• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

1118807-13-8 supplier

Background Testicular germ cell tumors (TGCTs) respond well to cisplatin-based chemotherapy

August 8, 2017 by Katherine Lewis Leave a Comment

Background Testicular germ cell tumors (TGCTs) respond well to cisplatin-based chemotherapy and show a low incidence of attained resistance compared to most somatic tumors. genes showed that they participate in a variety of different and widely distributed functional groups and biochemical pathways. Database mining showed significant association of genes (n = 41) induced by cisplatin … [Read more…]

Posted in: Blogging Tagged: 1118807-13-8 supplier, Rabbit Polyclonal to MARK2

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by